Tiziana Rossetti boasts an impressive career in the world of venture capital and life sciences. With extensive experience in investments in early stage start-ups, particularly in the healthcare and life science sectors, Rossetti has held key roles at esteemed organizations such as Sofinnova Partners, Innogest Capital, and Merck Ventures. Before venturing into the world of venture capital, Rossetti pursued an academic career with a PhD in Clinical Neuroscience from Royal Holloway University of London and a Master's Degree in Neurobiology from La Sapienza University of Rome. Additionally, Rossetti completed a MedTech Start-up Business school program at the University of Tubingen in Germany and a Business and Entrepreneurship Program at Santa Clara University as a Fulbright scholar. Prior to joining the world of venture capital, Rossetti was the CEO and founder of Cogmaze Diagnostics and held research associate and postdoctoral researcher positions at institutions such as the Medical Research Council and the Hertie-Institut für klinische Hirnforschung. Overall, Rossetti's vast experience and expertise make her a valuable asset to the world of venture capital and the healthcare industry.